Cargando…

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells

BACKGROUND: BRK is, a non-receptor tyrosine kinase, overexpressed in approximately 85% of human invasive ductal breast tumors. It is not clear whether BRK expression correlates with breast cancer subtypes, or the expression has prognostic or diagnostic significance. Herein, we investigated the corre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miah, Sayem, Bagu, Edward, Goel, Raghuveera, Ogunbolude, Yetunde, Dai, Chenlu, Ward, Alison, Vizeacoumar, Frederick S., Davies, Gerald, Vizeacoumar, Franco J., Anderson, Deborah, Lukong, Kiven Erique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335685/ https://www.ncbi.nlm.nih.gov/pubmed/30651078 http://dx.doi.org/10.1186/s12885-018-5186-8

Ejemplares similares

FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition
por: Ogunbolude, Yetunde, et al.
Publicado: (2017)

Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation
por: Bagu, Edward T., et al.
Publicado: (2017)

Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates
por: Goel, Raghuveera Kumar, et al.
Publicado: (2018)

BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration
por: Miah, Sayem, et al.
Publicado: (2014)

Seeking a better understanding of the non-receptor tyrosine kinase, SRMS
por: Goel, Raghuveera Kumar, et al.
Publicado: (2023)

Understanding breast cancer – The long and winding road
por: Lukong, Kiven Erique
Publicado: (2017)

Triple negative breast cancer: approved treatment options and their mechanisms of action
por: Mandapati, Aditya, et al.
Publicado: (2022)

Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
por: Saha, Taniya, et al.
Publicado: (2022)

A Low-Cost Digital Microscope with Real-Time Fluorescent Imaging Capability
por: Hasan, Md. Mehedi, et al.
Publicado: (2016)

Molecular characterization of breast cancer cell lines through multiple omic approaches
por: Smith, Shari E., et al.
Publicado: (2017)

Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel
por: Plett, Riley, et al.
Publicado: (2022)

Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers
por: Ward, Alison K., et al.
Publicado: (2016)

Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer
por: Kirzinger, Morgan W. B., et al.
Publicado: (2019)

APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A
por: Wong, Lai, et al.
Publicado: (2020)

Biochemical characterization of INTS3 and C9ORF80, two subunits of hNABP1/2 heterotrimeric complex in nucleic acid binding
por: Vidhyasagar, Venkatasubramanian, et al.
Publicado: (2018)

Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
por: K. Bhanumathy, Kalpana, et al.
Publicado: (2021)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo
por: Miah, S, et al.
Publicado: (2012)

The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment
por: El Zawily, Amr, et al.
Publicado: (2017)

Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery
por: Vizeacoumar, Frederick S., et al.
Publicado: (2021)

Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy
por: Arna, Ananna Bhadra, et al.
Publicado: (2023)

Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment
por: Paul, James M., et al.
Publicado: (2016)

BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential
por: Miah, S., et al.
Publicado: (2019)

EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours
por: Toosi, Behzad M., et al.
Publicado: (2018)

Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects
por: Nwabo Kamdje, Armel Hervé, et al.
Publicado: (2020)

Tumor Microenvironment Uses a Reversible Reprogramming of Mesenchymal Stromal Cells to Mediate Pro-tumorigenic Effects
por: Nwabo Kamdje, Armel H., et al.
Publicado: (2020)

PhenoM: a database of morphological phenotypes caused by mutation of essential genes in Saccharomyces cerevisiae
por: Jin, Ke, et al.
Publicado: (2012)

Enhancing the throughput and multiplexing capabilities of next generation sequencing for efficient implementation of pooled shRNA and CRISPR screens
por: Islam, Md. Fahmid, et al.
Publicado: (2017)

Expression-based analyses indicate a central role for hypoxia in driving tumor plasticity through microenvironment remodeling and chromosomal instability
por: Jing, Anqi, et al.
Publicado: (2018)

Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog
por: Nwabo Kamdje, Armel Herve, et al.
Publicado: (2017)

Mesenchymal stromal cells’ role in tumor microenvironment: involvement of signaling pathways
por: Nwabo Kamdje, Armel Herve, et al.
Publicado: (2017)

Simulated Microgravity Reduces Focal Adhesions and Alters Cytoskeleton and Nuclear Positioning Leading to Enhanced Apoptosis via Suppressing FAK/RhoA-Mediated mTORC1/NF-κB and ERK1/2 Pathways
por: Zhao, Tuo, et al.
Publicado: (2018)

High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: Interaction with IQ motif-containing factors
por: Robinson, Tyler JW, et al.
Publicado: (2013)

Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma
por: Arnason, Terra G., et al.
Publicado: (2022)

RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs
por: Robinson, Tyler J. W., et al.
Publicado: (2013)

A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers
por: Elhasasna, Hussain, et al.
Publicado: (2022)

An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer
por: Auslander, Noam, et al.
Publicado: (2017)

Identification of novel genes involved in apoptosis of HIV-infected macrophages using unbiased genome-wide screening
por: Dong, Simon X. M., et al.
Publicado: (2021)

Integrating high-throughput genetic interaction mapping and high-content screening to explore yeast spindle morphogenesis
por: Vizeacoumar, Franco J., et al.
Publicado: (2010)

Sympathetic signaling facilitates progression of neuroendocrine prostate cancer
por: Dwivedi, Shubham, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h9f3s51eedoiaq94kfgt781ibl